...
机译:基于莫西沙星和左氧氟沙星的三联疗法在持续性幽门螺杆菌感染二线治疗中的优势:荟萃分析
Department of Gastroenterology The First Affiliated Hospital of Nanjing Medical University Nanjing China;
Department of Gastroenterology The First Affiliated Hospital of Nanjing Medical University Nanjing China;
Department of Gastroenterology The First Affiliated Hospital of Nanjing Medical University Nanjing China;
Department of Gastroenterology The First Affiliated Hospital of Nanjing Medical University Nanjing China;
Department of Gastroenterology The First Affiliated Hospital of Nanjing Medical University Nanjing China;
PPI; Bismuth; Levofloxacin; Moxifloxacin; Fluoroquinolone; Helicobacter; Eradication rate; Second-line treatment;
机译:含莫西沙星的三联疗法与含铋的四联疗法对幽门螺杆菌感染的二线治疗:荟萃分析
机译:基于莫西沙星的三联疗法与基于克拉霉素的三联疗法对幽门螺杆菌感染的一线治疗:一项随机对照试验的荟萃分析。
机译:基于左氧氟沙星和克拉霉素的三联疗法作为幽门螺杆菌感染的一线和二线治疗:一项具有交叉设计的随机比较试验。
机译:无线治疗胶囊对幽门螺杆菌感染的pH测量的设计
机译:幽门螺杆菌感染后恒河猴胃粘蛋白寡糖分析及幽门螺杆菌外膜蛋白表达的转录调控
机译:二线治疗后的长期幽门螺杆菌再感染率:含铋四联疗法与莫西沙星三联疗法
机译:基于三联疗法的莫西沙星治疗幽门螺杆菌感染的疗效:随机临床试验的系统评价和荟萃分析